Global In–Vitro Diagnostics (IVDs) Medical Device Market Growth 2023-2029

Global In–Vitro Diagnostics (IVDs) Medical Device Market Growth 2023-2029

The global In–Vitro Diagnostics (IVDs) Medical Device market size is projected to grow from US$ 102850 million in 2022 to US$ 146630 million in 2029; it is expected to grow at a CAGR of 146630 from 2023 to 2029.

The key manufacturers of In-Vitro Diagnostics (IVDs) medical devices in the world include Roche, Abbott, Danaher, Siemens Healthcare, Thermo Fisher Scientific, Sysmex and BioMerieux, among which the top three manufacturers account for more than 40% of the market share. The global production of In-Vitro Diagnostics (IVDs) medical devices is mainly distributed in China, USA and Europe, among which China is the largest production region, accounting for nearly 10% of the market share. In terms of products, the growth rate of consumables is faster than that of instruments. At present, the market share exceeds 80%. In terms of application, hospital is the first application field, with more than 50% market share, followed by laboratory.

In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.

In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.

A medical device is an in vitro diagnostic medical device (IVD) if it is a reagents, calibrator, control material, kit, specimen receptacle, software, instrument, apparatus, equipment or system, whether used alone or in combination with other diagnostic goods for in vitro use.

LPI (LP Information)' newest research report, the “In–Vitro Diagnostics (IVDs) Medical Device Industry Forecast” looks at past sales and reviews total world In–Vitro Diagnostics (IVDs) Medical Device sales in 2022, providing a comprehensive analysis by region and market sector of projected In–Vitro Diagnostics (IVDs) Medical Device sales for 2023 through 2029. With In–Vitro Diagnostics (IVDs) Medical Device sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In–Vitro Diagnostics (IVDs) Medical Device industry.

This Insight Report provides a comprehensive analysis of the global In–Vitro Diagnostics (IVDs) Medical Device landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on In–Vitro Diagnostics (IVDs) Medical Device portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global In–Vitro Diagnostics (IVDs) Medical Device market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In–Vitro Diagnostics (IVDs) Medical Device and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In–Vitro Diagnostics (IVDs) Medical Device.

This report presents a comprehensive overview, market shares, and growth opportunities of In–Vitro Diagnostics (IVDs) Medical Device market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Consumables
Instruments

Segmentation by application
Hospital
Laboratory
Household

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global In–Vitro Diagnostics (IVDs) Medical Device market?

What factors are driving In–Vitro Diagnostics (IVDs) Medical Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do In–Vitro Diagnostics (IVDs) Medical Device market opportunities vary by end market size?

How does In–Vitro Diagnostics (IVDs) Medical Device break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.